Literature DB >> 20433544

The frequency and functional impact of overlapping hypertension on hypertrophic cardiomyopathy: a single-center experience.

Farhan Aslam1, Attiya Haque, Joanne Foody, Jamshid Shirani.   

Abstract

Between 1995 and 2005, 196 adults with hypertrophic cardiomyopathy (HCM) were evaluated. Among these, 122 (62%, group 1) patients also had systemic hypertension. The clinical presentation, management, outcome, and echocardiographic findings of these patients were compared with 74 (38%, group 2) patients without systemic hypertension. Patients in group 1 were older at the time of HCM diagnosis and had a higher prevalence of diabetes (28% vs 9%; P=.02) and coronary artery disease (40% vs 25%; P=.03). In addition, echocardiography showed a significantly higher prevalence of systolic anterior motion of the anterior mitral valve in association with dynamic left ventricular outflow obstruction (52% vs 19%; P=.02) and mitral annular calcification (27% vs 13%; P=.03) in group 1 patients. Left ventricular wall thickness (17 mm vs 19 mm), end-diastolic diameter (42 mm vs 42 mm), resting outflow tract gradient >30 mm Hg (17% vs 16%), and ejection fraction (65% vs 64%) were similar in the two groups. HCM frequently coexists with systemic hypertension in the adult population. Presence of systemic hypertension in HCM patients is associated with older age and higher risk of diabetes, coronary artery disease, and noncardiac death.

Entities:  

Mesh:

Year:  2010        PMID: 20433544      PMCID: PMC8673039          DOI: 10.1111/j.1751-7176.2009.00251.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  9 in total

1.  Hypertrophic cardiomyopathy in the elderly.

Authors:  L M Shapiro
Journal:  Br Heart J       Date:  1990-05

2.  Pompe's disease presenting as hypertrophic myocardiopathy with Wolff-Parkinson-White syndrome.

Authors:  B H Bulkley; G M Hutchins
Journal:  Am Heart J       Date:  1978-08       Impact factor: 4.749

3.  Hypertrophic cardiomyopathy: a discussion of nomenclature.

Authors:  B J Maron; S E Epstein
Journal:  Am J Cardiol       Date:  1979-06       Impact factor: 2.778

4.  The heterogeneity of hypertrophic cardiomyopathy: an autopsy and one dimensional echocardiographic study.

Authors:  J Y Wei; J L Weiss; B H Bulkley
Journal:  Am J Cardiol       Date:  1980-01       Impact factor: 2.778

5.  Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients.

Authors:  B J Maron; J S Gottdiener; S E Epstein
Journal:  Am J Cardiol       Date:  1981-09       Impact factor: 2.778

Review 6.  Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review.

Authors:  E D Wigle; Z Sasson; M A Henderson; T D Ruddy; J Fulop; H Rakowski; W G Williams
Journal:  Prog Cardiovasc Dis       Date:  1985 Jul-Aug       Impact factor: 8.194

7.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

8.  Hypertensive hypertrophic cardiomyopathy of the elderly.

Authors:  E J Topol; T A Traill; N J Fortuin
Journal:  N Engl J Med       Date:  1985-01-31       Impact factor: 91.245

Review 9.  Hypertrophic and hypertensive hypertrophic cardiomyopathy--a true association?

Authors:  Dimitris P Papadopoulos; Vasilios Papademetriou
Journal:  Angiology       Date:  2009-02-23       Impact factor: 3.619

  9 in total
  8 in total

1.  Prevalence, clinical correlates, and functional impact of subaortic ventricular septal bulge (from the Baltimore Longitudinal Study of Aging).

Authors:  Marco Canepa; Omar Malti; Melissa David; Majd AlGhatrif; James B Strait; Pietro Ameri; Claudio Brunelli; Edward G Lakatta; Luigi Ferrucci; Theodore P Abraham
Journal:  Am J Cardiol       Date:  2014-06-19       Impact factor: 2.778

Review 2.  Sleep-disordered breathing in hypertrophic cardiomyopathy: challenges and opportunities.

Authors:  Tomas Konecny; Virend K Somers
Journal:  Chest       Date:  2014-07       Impact factor: 9.410

3.  Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy.

Authors:  Marco Canepa; Lars L Sorensen; Iraklis Pozios; Veronica L Dimaano; Hong-Chang Luo; Aurelio C Pinheiro; James B Strait; Claudio Brunelli; M Roselle Abraham; Luigi Ferrucci; Theodore P Abraham
Journal:  Am J Cardiol       Date:  2013-10-15       Impact factor: 2.778

Review 4.  Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly.

Authors:  Marco Canepa; Iraklis Pozios; Pier Filippo Vianello; Pietro Ameri; Claudio Brunelli; Luigi Ferrucci; Theodore P Abraham
Journal:  Heart       Date:  2016-04-27       Impact factor: 5.994

5.  Mechanical dyssynchrony and diastolic dysfunction are common in LVH: a pilot correlation study using Doppler echocardiography and CZT gated-SPECT MPI.

Authors:  Szu-Ying Tsai; Shan-Ying Wang; Yu-Chien Shiau; Yen-Wen Wu
Journal:  Sci Rep       Date:  2018-03-08       Impact factor: 4.379

6.  Strain Analysis of Left Ventricular Function in the Association of Hypertrophic Cardiomyopathy and Systemic Arterial Hypertension.

Authors:  Thereza Cristina Pereira Gil; Marcia Bueno Castier; Alyne Freitas Pereira Gondar; Ana Ferreira Sales; Marceli de Oliveira Santos; Fernanda Cristina da Silva de Lima; Ricardo Mourilhe-Rocha
Journal:  Arq Bras Cardiol       Date:  2019-09-02       Impact factor: 2.000

7.  Reversible Treatment of Pressure Overload-Induced Left Ventricular Hypertrophy through Drd5 Nucleic Acid Delivery Mediated by Functional Polyaminoglycoside.

Authors:  Xiaoliang Jiang; Meiyu Shao; Xue Liu; Xing Liu; Xu Zhang; Yuming Wang; Kunlun Yin; Shuiyun Wang; Yang Hu; Pedro A Jose; Zhou Zhou; Fu-Jian Xu; Zhiwei Yang
Journal:  Adv Sci (Weinh)       Date:  2021-01-06       Impact factor: 16.806

8.  Ventricular Sigmoid Septum as a Risk Factor for Anthracycline-Induced Cancer Therapeutics-Related Cardiac Dysfunction in Patients With Malignant Lymphoma.

Authors:  Takafumi Nakayama; Yoshiko Oshima; Yasuhiro Shintani; Junki Yamamoto; Masashi Yokoi; Tsuyoshi Ito; Kazuaki Wakami; Shuichi Kitada; Toshihiko Goto; Hiroya Hashimoto; Shigeru Kusumoto; Tomonori Sugiura; Shinsuke Iida; Yoshihiro Seo
Journal:  Circ Rep       Date:  2022-03-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.